• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A pharmaceutical aqueous solution comprising cisatracurium, or a pharmaceutically acceptable salt thereof, a derivative of sulfoalkylether- β -cyclodextrin and an acid buffer solution. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2658115A1
    申请号:ES201730681
    申请日:2017-05-10
    公开日:2018-03-08
    发明作者:Pablo CID；Sergio Ruiz
    申请人:Farmhispania SA；
    IPC主号:
    专利说明:

    image 1
    image2
    image3
    image4
    image5
    image6
    image7
    image8
    image9
    权利要求:
    Claims (1)
    [1]
    image 1
    image2
    类似技术:
    公开号 | 公开日 | 专利标题
    PH12016501693A1|2016-10-03|2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom
    EA201892007A1|2019-01-31|3-DESOXY DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ON ITS BASIS
    UY35684A|2015-02-27|FORMULATION OF INHIBITORS OF THE TYPESIN KINASE OF BAZO |
    BR112018015855A2|2018-12-26|The medicine constituent containing a sulfa derivative and it
    AR098168A1|2016-05-04|STABLE FORMULATION OF GLULISINE INSULIN
    BR112019001980A2|2019-05-07|oxide inhibitor and method of preparation and application thereof
    EA201990506A1|2019-09-30|PHARMACEUTICAL COMPOSITION
    EA201892119A1|2019-02-28|DRUGS, OBTAINED BY COMBINING AGONIST FXR AND ARB
    EA201890532A1|2018-09-28|NEW ANNELED BENZAMIDES
    EA201692298A1|2017-03-31|DERIVATIVES OF CARBOXAMIDES
    BR112017012337A2|2018-02-27|METHOD FOR TREATING SICKLE DISEASE, AT2 RECEPTOR AGONIST, OR A PHARMACEUTICALLY ACCEPTABLE SALT, SOLVATE OR PRO-DRUG OF THE SAME, USE OF AN AT2 RECEPTOR AGONIST, OR A PHARMACEUTICALLY ACCEPTABLE, PHARMACEUTIC, OR PHARMACEUTICAL, SALT, OR PHARMACEUTICALLY ACCURACY, OR PHARMACEUTICALLY, OR PHARMACEUTICAL SALT, OR PHARMACEUTICALLY ACCURACY, OR PHARMACEUTICALLY ACCURACY, OR PHARMACEUTICALLY ACCURACY, OR PHARMACEUTICALLY ACHIEVABLE, OR PHARMACEUTICALLY, OR PHARMACEUTICALLY, PHARMACEUTICAL, PHARMACEUTICAL, OR PHARMACEUTICALLY ACHIEVEMENT. , AND, COMBINATION PRODUCT.
    EA201891682A1|2018-12-28|AZACYCLIC AMID DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL APPLICATION
    BR112015021480A2|2017-07-18|intrathecal hydromorphone solutions having improved stability
    ES2611776T3|2017-05-10|Use of tungsten salts | for the treatment of female sterility in non-diabetic mammals
    EA201890534A1|2018-09-28|NEW ANNELED PHENOXYCETAMIDES
    ES2658115A1|2018-03-08|Compositions of cisatracurium and beta-cyclodextrin derivatives. |
    ES2482290A1|2014-08-01|Symmetric polar inhibitors of choline kinase with antitumor activity |
    MX371090B|2020-01-16|Hydantoin derivative-containing pharmaceutical composition.
    EA202091169A1|2020-08-06|SMAC MIMETICS USED AS IAP INHIBITORS AND THEIR APPLICATION
    RU2017108908A|2018-09-21|SUBSTITUTED IN POSITION C-4 "MACROLIDE DERIVATIVE
    EA201890477A1|2018-08-31|INCAPSULATED COMPOSITION OF FINGOLIMODA
    AR107163A1|2018-03-28|QUINASE INHIBITORS
    AR106559A1|2018-01-24|WATERPROOF SUSPENSION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARATION
    TH1701006461A|2019-06-14|An amino-hydrothiazine derivative fused by tetrahydrofurane, useful in the treatment of Alzheimer's disease.
    EA202090368A1|2020-06-09|LYSOPHOSPHATID ACID RECEPTOR COMPOUNDS 1 |
    同族专利:
    公开号 | 公开日
    GB201608191D0|2016-06-22|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2008065142A1|2006-11-29|2008-06-05|N.V. Organon|Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative|
    WO2013189800A1|2012-06-22|2013-12-27|Farmhispania S.A.|Cisatracurium and beta-cyclodextrin derivative compositions|
    法律状态:
    2018-07-04| FA2A| Application withdrawn|Effective date: 20180628 |
    优先权:
    申请号 | 申请日 | 专利标题
    GB16081911|2016-05-10|
    GBGB1608191.1A|GB201608191D0|2016-05-10|2016-05-10|Cisatracurium and beta-cyclodextrin derivative compositions|
    [返回顶部]